Related Experiment Video

Updated: Mar 13, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K

A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors

Jerome A Staal1,2, Yanxin Pei3, Brian R Rood4

  • 1Multiple Sclerosis Department, Florey Institute of Neuroscience and Mental Health, Melbourne, VIC 3052, Australia. jstaal@florey.edu.au.

International Journal of Molecular Sciences
|October 25, 2016
PubMed

Insights

Childhood brain tumors like medulloblastoma are deadly. New proteomic methods reveal how c-MYC gene amplification drives aggressive tumors, offering hope for targeted therapies.

Area of Science:

  • Pediatric oncology
  • Molecular biology
  • Genomics

Background:

  • Medulloblastoma is the most common malignant pediatric brain tumor and a leading cause of cancer-related death in children.
  • Effective treatment with minimal neurodevelopmental damage is a major clinical challenge.
  • Understanding tumor biology is crucial for developing targeted therapies and improving patient survival.

Purpose of the Study:

  • To investigate the functional impact of genomic abnormalities, specifically c-MYC amplification, in aggressive medulloblastoma.
  • To bridge the gap between genotype and phenotype using advanced proteomic techniques.
  • To establish a new platform for understanding cancer biology through integrated proteogenomic approaches.

Main Methods:

  • Analysis of genomic copy number alterations in medulloblastoma.
  • Application of quantitative proteomic techniques.
  • Integrated proteogenomic analysis of c-MYC-amplified medulloblastoma.

Main Results:

  • c-MYC amplification is a significant risk factor for aggressive medulloblastoma with metastatic potential.
  • Quantitative proteomics provides novel insights into the functional biology of these aggressive tumors.
  • Proteogenomic approaches link genomic abnormalities to functional cellular changes.

Conclusions:

  • Integrated proteogenomic strategies offer a powerful platform for understanding cancer biology.
  • These approaches provide functional context to genomic alterations in medulloblastoma.
  • This research paves the way for novel therapeutic strategies targeting aggressive pediatric brain tumors.
Keywords:
MYCmedulloblastomaquantitative proteomics

More Related Videos

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.5K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K